Prognosis
Moderna Seeks Full FDA Approval for Its Covid-19 Vaccine
- Shot was first cleared in U.S. on emergency basis last year
- Application follows similar filing by rival Pfizer last month
This article is for subscribers only.
Moderna Inc. said it is seeking a full approval for its Covid-19 vaccine, a move that could make a shot cleared on an emergency basis during the pandemic into a stable source of revenue for years to come.
The company said in a statement Tuesday that it will submit data to the Food and Drug Administration on a rolling basis in coming weeks to support the application for use of the vaccine in people 18 and older.